Joanne Magoon

Title: Joanne Magoon: Innovator in Anti-Angiogenic Agents

Introduction

Joanne Magoon is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of pharmacology, particularly in the development of anti-angiogenic agents. Her innovative work has the potential to impact various medical applications.

Latest Patents

Joanne Magoon holds a patent for the "Use of catecholamines and related compounds as anti-angiogenic agents." This patent describes a catecholamine or related compound that has (S)-configuration at the β-carbon, along with its physiologically tolerated salts, prodrugs, and functional derivatives. The invention highlights the use of these compounds as effective anti-angiogenic agents, which can be crucial in treating conditions related to abnormal blood vessel growth.

Career Highlights

Joanne Magoon is affiliated with the National Research Council of Canada, where she conducts her research and development. Her work is characterized by a strong focus on innovative solutions in the medical field. She has successfully navigated the complexities of patenting her inventions, showcasing her expertise in both research and intellectual property.

Collaborations

Joanne has collaborated with esteemed colleagues such as Suwatchai Jarussophon and Yasuo Konishi. These partnerships have enriched her research and contributed to the advancement of her projects.

Conclusion

Joanne Magoon's contributions to the field of anti-angiogenic agents exemplify her dedication to innovation and research. Her patent reflects a significant advancement in pharmacological applications, showcasing her role as a leading inventor in her field.